FTC sues Hims & Hers; company vows to fight the claims

Hims & Hers Health, Inc. (NYSE: HIMS) issued a statement rejecting a lawsuit filed against it by the Federal Trade Commission, calling the claims "baseless" and saying it plans to "vigorously defend" itself.

The company said the FTC lawsuit "disregards substantial evidence" it provided during a nearly three-year investigation, "ignores established state laws and industry standards in telehealth, and contorts the law to try to manufacture claims."

Hims & Hers said the action was "not enforcement grounded in consumer protection" but rather "an effort to generate headlines" at its expense.

The company also addressed data privacy, stating that its privacy policy gives customers the ability to choose how their data is used, and that information shared with healthcare providers is used only in providing care.

Hims & Hers, which was founded in 2017, operates a telehealth platform offering access to medical care and wellness services. The details of the FTC's specific allegations were not disclosed in the company's statement.

You May Also Be Interested In

• JPMorgan Double Downgrades Gulfport Energy (GPOR) to Underweight
• Sk Telecom (SKM) call put ratio 1.7 calls 1 put on 9900 contracts
• Stifel on Dyne Therapeutics Inc. (DYN): 'we'd be buyers on weakness'